As a first-generation Korean-American scientist, Hee Jin Kim has carved a path that blends scientific rigor with private objective. A devoted immunology researcher and cell remedy skilled, she has made vital contributions to advancing therapies in each oncology and autoimmune illness. Her work spans analysis at Metropolis of Hope, one of many nation’s main most cancers institutes, in addition to efforts in autoimmune-focused cell therapies and B-cell therapies concentrating on circumstances comparable to a number of sclerosis, arthritis, lupus, and scleroderma.
Kim’s journey has been outlined by resilience and dedication, overcoming cultural {and professional} limitations to realize success.
“I turned concerned in biotechnology as a result of I wished a profession the place I may each problem myself and make an actual affect. As the primary in my household to graduate from school and construct knowledgeable profession within the U.S., I felt strongly about pursuing a path that not solely pushed me ahead but in addition opened doorways for others who would possibly come after me,” Kim says.

A Love of Folks and Science
From an early age, Kim mixed her deep curiosity about science with a need to assist others. She started volunteering at UCLA’s pediatric hospital, the place she witnessed the struggles of youngsters battling leukemia. Later, she gained firsthand expertise within the emergency room at Olympia Medical Heart and with long-term most cancers sufferers. These encounters impressed her determination to review biology on the College of California, San Diego, setting her on a course towards immunology and biotechnology.
“I’ve mixed private motivation, scientific curiosity, and real-world affect,” Kim says, “shifting from bedside encounters as a volunteer to analysis and growth on the slicing fringe of biotechnology.”
A Private Funding in Science
Right this moment, Kim works at GeneFab LLC in Alameda, California, the place she performs a key position in creating scalable cell remedy platforms designed to speed up affected person entry to high-quality remedies.
Her skilled mission is deeply private. Each her mom and grandmother endure from rheumatoid arthritis, giving her an intimate understanding of the toll autoimmune illnesses can take. This angle fuels her dedication to enhance affected person outcomes via the event of higher therapies.
“Biotech analysis gave me the chance to mix curiosity, problem-solving, and innovation with the possibility to create one thing that would really change lives,” Kim says.
Resilience and Discovery as a Feminine Biotech Chief
Kim’s path has not been with out obstacles. As the primary in her household to navigate larger schooling and a profession in science, she lacked a roadmap and infrequently needed to chart her personal course.
“At instances it felt overwhelming to determine every subsequent step by myself, particularly in such a aggressive and fast-moving discipline,” Kim admits.
Over time, she constructed a community of friends and colleagues, related with mentors, and requested many questions in pursuit of gaining information. She realized to belief her instincts and make onerous selections.
She additionally realized the ability of being resilient, particularly when experiments generally didn’t go as hoped. These “setbacks,” Kim found, typically led to new insights and a special method.
One in all Kim’s main accomplishments concerned advancing scientific initiatives to assist fight T-cell lymphoma.
“I accomplished each in vitro and in vivo experiments that demonstrated the potential of genetically modified cells to successfully goal and struggle lymphoma, contributing beneficial knowledge to this space of analysis,” says Kim.
Wanting Forward
Kim’s long-term imaginative and prescient is to stay on the forefront of biotechnology analysis whereas serving for instance for others getting into the sector. She is especially dedicated to inspiring girls, minorities, and first-generation college students to see a spot for themselves in science.
“Science has the ability to alter lives, and various voices are wanted to drive that change,” she says.

